Holen Sie sich die Stockscreener-App
13.80
1.40%
0.1987
Schlusskurs vom Vortag:
$13.60
Offen:
$13.16
24-Stunden-Volumen:
606.61K
Relative Volume:
0.37
Marktkapitalisierung:
$1.23B
Einnahmen:
$-249.00K
Nettoeinkommen (Verlust:
$-187.60M
KGV:
-5.5195
EPS:
-2.5
Netto-Cashflow:
$-201.88M
1W Leistung:
-3.70%
1M Leistung:
+2.76%
6M Leistung:
+159.21%
1J Leistung:
+141.93%
1-Tages-Spanne:
$13.11
$13.88
1-Wochen-Bereich:
$13.11
$14.37
52-Wochen-Spanne:
$2.865
$16.96
Amylyx Pharmaceuticals Inc Stock (AMLX) Company Profile
Firmenname
Amylyx Pharmaceuticals Inc
Sektor
Branche
Telefon
617-683-0917
Adresse
43 THORNDIKE STREET, CAMBRIDGE
Vergleichen Sie AMLX mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
AMLX
Amylyx Pharmaceuticals Inc
|
13.78 | 1.45B | -249.00K | -187.60M | -201.88M | -2.50 |
|
VRTX
Vertex Pharmaceuticals Inc
|
425.95 | 109.22B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
629.53 | 67.50B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
424.36 | 57.35B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
838.08 | 50.87B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
184.12 | 39.72B | 447.02M | -1.18B | -868.57M | -6.1812 |
Amylyx Pharmaceuticals Inc Stock (AMLX) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-07-10 | Fortgesetzt | Goldman | Buy |
| 2025-06-24 | Eingeleitet | Guggenheim | Buy |
| 2025-06-17 | Eingeleitet | Citigroup | Buy |
| 2025-05-30 | Eingeleitet | TD Cowen | Buy |
| 2025-04-07 | Hochstufung | Mizuho | Neutral → Outperform |
| 2024-11-18 | Hochstufung | Robert W. Baird | Neutral → Outperform |
| 2024-10-23 | Hochstufung | BofA Securities | Neutral → Buy |
| 2024-03-18 | Herabstufung | Mizuho | Buy → Neutral |
| 2024-03-11 | Herabstufung | Leerink Partners | Outperform → Market Perform |
| 2024-03-11 | Herabstufung | Robert W. Baird | Outperform → Neutral |
| 2024-03-08 | Herabstufung | Evercore ISI | Outperform → In-line |
| 2024-03-08 | Herabstufung | Goldman | Buy → Neutral |
| 2024-01-03 | Eingeleitet | Robert W. Baird | Outperform |
| 2023-12-12 | Eingeleitet | Deutsche Bank | Buy |
| 2023-07-24 | Hochstufung | Goldman | Neutral → Buy |
| 2023-03-31 | Eingeleitet | Mizuho | Buy |
| 2023-01-05 | Eingeleitet | BofA Securities | Buy |
| 2022-05-25 | Eingeleitet | Citigroup | Buy |
| 2022-04-01 | Herabstufung | Goldman | Buy → Neutral |
Alle ansehen
Amylyx Pharmaceuticals Inc Aktie (AMLX) Neueste Nachrichten
Will Amylyx Pharmaceuticals Inc. stock benefit from commodity pricesWeekly Volume Report & Weekly Breakout Opportunity Watchlist - newser.com
Real time social sentiment graph for Amylyx Pharmaceuticals Inc.Analyst Upgrade & Low Drawdown Trading Strategies - newser.com
Will Amylyx Pharmaceuticals Inc. price bounce be sustainableEarnings Miss & Consistent Profit Trading Strategies - newser.com
What the charts say about Amylyx Pharmaceuticals Inc. today2025 Top Gainers & Scalable Portfolio Growth Methods - newser.com
Is Amylyx Pharmaceuticals Inc. stock attractive for long term wealth buildingTrade Ideas & Verified Technical Trade Signals - newser.com
Amylyx Pharmaceuticals to Present at Upcoming Investor Conferences - The Globe and Mail
Trend analysis for Amylyx Pharmaceuticals Inc. this week2025 Winners & Losers & Weekly Consistent Profit Watchlists - newser.com
Real time alert setup for Amylyx Pharmaceuticals Inc. performanceWeekly Investment Recap & Fast Gain Stock Trading Tips - newser.com
Is Amylyx Pharmaceuticals Inc. stock a defensive play in 2025July 2025 Review & Safe Capital Investment Plans - newser.com
Applying Wyckoff theory to Amylyx Pharmaceuticals Inc. stockJuly 2025 Market Mood & Safe Swing Trade Setups - newser.com
Will Amylyx Pharmaceuticals Inc. stock deliver better than expected guidanceTrade Signal Summary & Safe Entry Momentum Stock Tips - newser.com
What’s the recovery path for long term holders of Amylyx Pharmaceuticals Inc.Weekly Market Outlook & Free Weekly Chart Analysis and Trade Guides - newser.com
Using portfolio simulators with Amylyx Pharmaceuticals Inc. includedTrade Volume Report & Short-Term Trading Opportunity Alerts - newser.com
Is Amylyx Pharmaceuticals Inc. stock in correction or buying zoneJuly 2025 Review & Daily Technical Forecast Reports - newser.com
Y Intercept Hong Kong Ltd Purchases New Position in Amylyx Pharmaceuticals, Inc. $AMLX - MarketBeat
What analysts say about Amylyx Pharmaceuticals Inc stockEconomic Indicators Overview & Free Stay Ahead With Picks - earlytimes.in
Measuring Amylyx Pharmaceuticals Inc.’s beta against major indicesJuly 2025 Breakouts & Detailed Earnings Play Strategies - newser.com
Amylyx Pharmaceuticals (AMLX) Projected to Post Earnings on Thursday - MarketBeat
Using flow based indicators on Amylyx Pharmaceuticals Inc.July 2025 Update & AI Powered Market Entry Strategies - newser.com
Important Notice to Long-Term Shareholders of Amylyx - GlobeNewswire
Amylyx Pharmaceuticals to Report Third Quarter 2025 Financial Results on November 6, 2025 - Business Wire
Q3 Earnings Estimate for AMLX Issued By Lifesci Capital - MarketBeat
Amylyx Pharmaceuticals Advances Phase 3 Study for Post-Bariatric Hypoglycemia Treatment - MSN
Finanzdaten der Amylyx Pharmaceuticals Inc-Aktie (AMLX)
Umsatz
Nettogewinn
Free Cashflow
ENV
1.18%
0.25%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):